Brookfield Asset Management Inc. Guardant Health, Inc. Transaction History

Brookfield Asset Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $971,740 - $1.36 Million	22,257 Added 290.18%	29,927 $1.61 Million
Q2 2022 Nov 16, 2022	SELL	$28.82 - $77.35 $641,446 - $1.72 Million	-22,257 Reduced 74.37%	7,670 $309,000
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $805,374 - $2.16 Million	-27,945 Reduced 78.46%	7,670 $309,000
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $512,173 - $1.07 Million	10,615 Added 42.46%	35,615 $2.36 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $1.51 Million - $2.44 Million	25,000 New	25,000 $2.03 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.64B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.